Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2

被引:64
作者
Morisaki, H
Fujimoto, A
Ando, A
Nagata, Y
Ikeda, K
Nakanishi, M
机构
[1] NATL INST LONGEV SCI,DEPT GERIATR RES,AICHI 474,JAPAN
[2] CHIBA UNIV,GRAD SCH SCI & TECHNOL,DEPT BIOTECHNOL,MATSUDO,CHIBA 271,JAPAN
关键词
D O I
10.1006/bbrc.1997.7590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cyclin-dependent kinase (Cdk) inhibitor p27 interrupts progression of the cell cycle by inhibiting various cyclin/Cdk activities. Since the protein level of p27 does not correlate with its mRNA level or protein synthesis rate in most cases, it is suggested that degradation of the protein may be regulated via an unidentified mechanism(s) involving a post-translational modification(s). We present evidence here that p27 phosphorylation is cell cycle-dependent and peaks in the late G1 phase and that the level of p27 protein is inversely correlated with its phosphorylation. Although both cyclin D1- and cyclin-E-dependent kinases are active in the late G1 phase in human fibroblasts, cyclin E/Cdk2 specifically phosphorylates p27 on threonine-187 in vitro. interestingly, ectopic expression of T187A revealed that it was far more stable in vivo than wild type p27. Thus, phosphorylation of p27 by cyclin El Cdk2 may affect the stability of its protein and play a role in how the protein functions. (C) 1997 Academic Press.
引用
收藏
页码:386 / 390
页数:5
相关论文
共 23 条
[1]   PHOSPHORYLATION OF SYNTHETIC VIMENTIN PEPTIDES BY CDC2 KINASE [J].
ANDO, S ;
TSUJIMURA, K ;
MATSUOKA, Y ;
TOKUI, T ;
HISANAGA, S ;
OKUMURA, E ;
UCHIYAMA, M ;
KISHIMOTO, T ;
YASUDA, H ;
INAGAKI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) :837-843
[2]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[3]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[4]   UBIQUITINATION OF THE G(1) CYCLIN CLN2P BY A CDC34P-DEPENDENT PATHWAY [J].
DESHAIES, RJ ;
CHAU, V ;
KIRSCHNER, M .
EMBO JOURNAL, 1995, 14 (02) :303-312
[5]   Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquintin-proteasome pathway [J].
Diehl, JA ;
Zindy, F ;
Sherr, CJ .
GENES & DEVELOPMENT, 1997, 11 (08) :957-972
[6]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[7]   HUMAN CYCLIN-E, A NEW CYCLIN THAT INTERACTS WITH 2 MEMBERS OF THE CDC2 GENE FAMILY [J].
KOFF, A ;
CROSS, F ;
FISHER, A ;
SCHUMACHER, J ;
LEGUELLEC, K ;
PHILIPPE, M ;
ROBERTS, JM .
CELL, 1991, 66 (06) :1217-1228
[8]   Rapid degradation of the G(1) cyclin Cln2 induced by CDK-dependent phosphorylation [J].
Lanker, S ;
Valdivieso, MH ;
Wittenberg, C .
SCIENCE, 1996, 271 (5255) :1597-1601
[9]   CLONING OR P57(KIP2), A CYCLIN-DEPENDENT KINASE INHIBITOR WITH UNIQUE DOMAIN-STRUCTURE AND TISSUE DISTRIBUTION [J].
LEE, MH ;
REYNISDOTTIR, I ;
MASSAGUE, J .
GENES & DEVELOPMENT, 1995, 9 (06) :639-649
[10]   P57(KIP2), A STRUCTURALLY DISTINCT MEMBER OF THE P21(CIP1) CDK INHIBITOR FAMILY, IS A CANDIDATE TUMOR-SUPPRESSOR GENE [J].
MATSUOKA, S ;
EDWARDS, MC ;
BAI, C ;
PARKER, S ;
ZHANG, PM ;
BALDINI, A ;
HARPER, JW ;
ELLEDGE, SJ .
GENES & DEVELOPMENT, 1995, 9 (06) :650-662